InvestorsObserver
×
News Home

Should You Buy Abeona Therapeutics Inc (ABEO) in Biotechnology Industry?

Wednesday, September 06, 2023 11:15 AM | InvestorsObserver Analysts

Mentioned in this article

Should You Buy Abeona Therapeutics Inc (ABEO) in Biotechnology Industry?

A rating of 94 puts Abeona Therapeutics Inc (ABEO) near the top of the Biotechnology industry according to InvestorsObserver. Abeona Therapeutics Inc's score of 94 means it scores higher than 94% of stocks in the industry. Abeona Therapeutics Inc also received an overall rating of 73, putting it above 73% of all stocks. Biotechnology is ranked 70 out of the 148 industries.

Overall Score - 73
ABEO has an Overall Score of 73. Find out what this means to you and get the rest of the rankings on ABEO!

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Abeona Therapeutics Inc Stock Today?

Abeona Therapeutics Inc (ABEO) stock is trading at $4.05 as of 11:13 AM on Wednesday, Sep 6, a drop of -$0.15, or -3.57% from the previous closing price of $4.20. The stock has traded between $4.01 and $4.43 so far today. Volume today is low. So far 14,773 shares have traded compared to average volume of 136,199 shares. Click Here to get the full Stock Report for Abeona Therapeutics Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App